Stat3 activation in urothelial stem cells leads to direct progression to invasive bladder cancer. - Wikidata - wikimedia - TriplyDB

Stat3 activation in urothelial stem cells leads to direct progression to invasive bladder cancer.

Stat3 activation in urothelial stem cells leads to direct progression to invasive bladder cancer.

http://www.wikidata.org/entity/Q42275760

about

Bladder Cancer Stem-Like Cells: Their Origin and Therapeutic Perspectives Targeting the tumor microenvironment: JAK-STAT3 signaling Normal and neoplastic urothelial stem cells: getting to the root of the problem Controversies and challenges in research on urogenital schistosomiasis-associated bladder cancer EZH2 in Bladder Cancer, a Promising Therapeutic Target Stem cell applications for pathologies of the urinary bladder Induction of human embryonic and induced pluripotent stem cells into urothelium.EGCG inhibits the growth and tumorigenicity of nasopharyngeal tumor-initiating cells through attenuation of STAT3 activation Current animal models of bladder cancer: Awareness of translatability (Review)IL-6 expression regulates tumorigenicity and correlates with prognosis in bladder cancer Overexpression of p16(INK4a) in urothelial carcinoma in situ is a marker for MAPK-mediated epithelial-mesenchymal transition but is not related to human papillomavirus infection.Balancing the innate immune system in tumor development.Modelling bladder cancer in mice: opportunities and challenges.δ-tocotrienol induces human bladder cancer cell growth arrest, apoptosis and chemosensitization through inhibition of STAT3 pathway.Loss of FOXA1 Drives Sexually Dimorphic Changes in Urothelial Differentiation and Is an Independent Predictor of Poor Prognosis in Bladder Cancer.Molecular subtypes of urothelial carcinoma are defined by specific gene regulatory systems Blocking PGE2-induced tumour repopulation abrogates bladder cancer chemoresistance.Metformin can block precancerous progression to invasive tumors of bladder through inhibiting STAT3-mediated signaling pathways Immunological basis in the pathogenesis and treatment of bladder cancer Functional and molecular characterization of cancer stem-like cells in bladder cancer: a potential signature for muscle-invasive tumors.The hyaluronic acid receptor CD44 coordinates normal and metaplastic gastric epithelial progenitor cell proliferation Loss of Sh3gl2/endophilin A1 is a common event in urothelial carcinoma that promotes malignant behavior.KRT14 marks a subpopulation of bladder basal cells with pivotal role in regeneration and tumorigenesis.Constitutive β-catenin activation induces male-specific tumorigenesis in the bladder urothelium Metformin represses bladder cancer progression by inhibiting stem cell repopulation via COX2/PGE2/STAT3 axis.Intrinsic basal and luminal subtypes of muscle-invasive bladder cancer.Chronic inflammation in urothelial bladder cancer.SOX2 Is a Marker for Stem-like Tumor Cells in Bladder Cancer Role of STAT3 and FOXO1 in the Divergent Therapeutic Responses of Non-metastatic and Metastatic Bladder Cancer Cells to miR-145.Role of STAT3 pathway in genitourinary tumors.STAT3 signaling is activated preferentially in tumor-initiating cells in claudin-low models of human breast cancer.Urothelial generation and regeneration in development, injury, and cancer.High NF-κB and STAT3 activity in human urothelial carcinoma: a pilot study.Cancer stem cells and epithelial-mesenchymal transition in urothelial carcinoma: Possible pathways and potential therapeutic approaches.Epithelial-mesenchymal transition promotes SOX2 and NANOG expression in bladder cancer.TGFβ1 Promotes Gemcitabine Resistance through Regulating the LncRNA-LET/NF90/miR-145 Signaling Axis in Bladder Cancer.In vivo disruption of an Rb-E2F-Ezh2 signaling loop causes bladder cancer.Inflammatory microenvironment in the initiation and progression of bladder cancer.Identification of BLCAP as a novel STAT3 interaction partner in bladder cancer.Prognostic Power of a Tumor Differentiation Gene Signature for Bladder Urothelial Carcinomas.

P2860

Q26771263-56536F9A-998D-4DE5-B375-46D63035FF4B Q26825658-5169F62B-2B33-4956-989A-8A9F2E9A3DE7 Q26825948-4184ABB6-ACEA-4EEE-AB1C-986725BB4A28 Q27008499-548C1795-AA6F-4C2E-86B2-F8E257A41418 Q28082054-E592AA0B-17FA-4AE0-B86F-4A0501043532 Q28085228-2011E3DC-3B11-4D6F-9D52-698D7840935D Q33551978-0D1D243D-6BBB-4806-96A2-A2A30255181D Q33803015-38B69638-1F34-4B58-8AFF-0FE402F66695 Q33962620-19E2C70A-F9E4-4F35-AC15-8371508D2422 Q34700730-5682A50C-FF7E-4D58-915C-0994AE629EDF Q34750035-2A937119-689B-416E-9F9D-A4AECE0B2EFD Q35236394-5DB117B3-6A72-47D8-AC4F-72B293DE2F8D Q35285703-E5C3F793-AB07-4E6C-B77C-BB2D4E708A4E Q35301664-87284CE6-384F-4664-8A3F-48EA65993E85 Q35568071-900AF680-CDDF-4A76-A59A-93B9F9896B45 Q35640830-63AFB45A-1987-40AC-B14A-84E79388FF61 Q35735937-F8A504A3-73A5-4C47-96BD-5100D1D01177 Q36005565-6AF24F02-D26A-4232-BF81-1945674AC873 Q36260118-98D5B82C-7B00-4F00-95D4-5192B8D70C80 Q36546605-B1A887EF-3DFB-4F8B-80B1-E0CCB7FD4A04 Q36890737-F919E5D1-B371-4ABC-B038-6BEBF2A593C7 Q36945929-A954175F-A8F6-46B4-82AE-988A5EC36791 Q37024540-E6C9CAF2-904A-47DF-837E-5329300D62FD Q37215956-19642CF9-FEEE-4357-8FC6-0B3EAF8EA65C Q37317523-2A221BD1-9FC4-44D5-A043-D4B4E184142F Q38222834-1EAD99D7-FC24-48EA-86A7-CF06E7A49F70 Q38564597-39540CD7-580F-4F0D-8E63-6A6482071543 Q38632090-9066C74F-3DFF-46CC-8C14-BC5F0611596B Q38715437-0EEC6B69-08AA-491B-9C9B-BF7B843800C6 Q38776978-B07DD142-D1BE-48C9-9D61-030E782C35B3 Q38988872-CE65AEEE-F761-4B59-8B36-417BD6C120BA Q39097235-9E94FF7A-5457-4592-A015-3E98739E0BE5 Q39267304-9AB33C85-ED30-455B-96F6-EEDF0914CD5B Q39428933-9AB5D616-DF07-48A2-B5A7-ED5D57FDA834 Q40316288-9E1F0A8C-0686-4140-82F9-6C4EF9CFD9A6 Q41481557-395BFB75-03BB-43D8-9521-5580F2640ECF Q42550010-5A2F75EA-B695-4F13-86D7-78C4A8B20611 Q46779353-21FBB344-D44A-4F52-866D-3D8A8CFEE05D Q47099158-D78014F3-3D81-41AC-AC86-E7CE22D0E08B Q47727562-1B8954D9-2EC3-4FB9-91C4-B759A31792B1

P2860

Stat3 activation in urothelial stem cells leads to direct progression to invasive bladder cancer.

http://www.wikidata.org/entity/Q42275760

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Stat3 activation in urothelial ...... on to invasive bladder cancer.

@en

Stat3 activation in urothelial ...... on to invasive bladder cancer.

@nl

type

label

Stat3 activation in urothelial ...... on to invasive bladder cancer.

@en

Stat3 activation in urothelial ...... on to invasive bladder cancer.

@nl

prefLabel

Stat3 activation in urothelial ...... on to invasive bladder cancer.

@en

Stat3 activation in urothelial ...... on to invasive bladder cancer.

@nl

P1433

Q42275760-53D9921D-4FC0-4355-9BEE-B0C2C0C8A426

P1476

Q42275760-651F035D-7CB9-4328-BE6B-5CE38689B8F6

P2093

Q42275760-2137A42E-CF2A-45AB-BD95-0C58EB28750A

Q42275760-37527F16-3ABE-432C-9448-5047B8964426

Q42275760-A682D2C5-ED3D-4058-B158-357239655BFC

Q42275760-F4B3E33D-2B07-4AC1-B623-198BBA2DD7ED

Q42275760-F994BCFE-661A-4F45-9F04-5DFE36B91F05

P2860

Q42275760-003A558F-E869-4987-B01D-A0B7AE137FC8

Q42275760-014CFE14-29CD-4D06-B796-CC3EEF0A890D

Q42275760-07FDCF58-3A5D-4B37-9E8F-2558CCBEA5B1

Q42275760-2556B11E-EED2-470A-B342-71484AD119B5

Q42275760-3F499724-367D-46BC-980A-25CBD791B197

Q42275760-41F3FF23-7BDE-4ECE-8F03-6D1579CD4CCE

Q42275760-5D4F5B93-5072-4511-BB91-26EF898A5CB3

Q42275760-6EA8A95E-47A6-46D7-8CD0-928F7B40FE1C

Q42275760-7D70CA8C-70C6-4D36-B351-37E5DE08B730

Q42275760-82B45473-555B-43F2-8CF3-3659CDE9398C

P304

Q42275760-F5ACB682-C625-4772-8C1B-86541D1FA425

P31

Q42275760-C8EDE29B-0C46-4157-8CA5-CE5764716660

P356

Q42275760-263A42CE-A7FA-496C-963B-5FB4240CDDB5

P407

Q42275760-4F3919BE-279C-4024-9080-8AB28567A4BF

P433

Q42275760-3D2D991A-B086-4464-BCB8-42FA7C1C75C8

P478

Q42275760-C84D816C-D68E-4800-936A-77A7349D3546

P577

Q42275760-AC6AE19D-6F4C-436A-A16C-F29D07E2CCE3

P5875

Q42275760-7B313C70-4F8D-423C-9708-90C1358BF0B7

P698

Q42275760-96FCEF64-D033-47D2-A061-48B17976AE0F

P932

Q42275760-9A70C881-DE94-4FB5-BF59-5746E92D7AC7

P356

0008-5472.CAN-11-3195

P1433

Cancer Research

P1476

Stat3 activation in urothelial ...... on to invasive bladder cancer.

@en

P2093

Diana Parra

http://www.w3.org/2001/XMLSchema#string

Erica Julianne Lay

http://www.w3.org/2001/XMLSchema#string

Keith Syson Chan

http://www.w3.org/2001/XMLSchema#string

Philip Levy Ho

http://www.w3.org/2001/XMLSchema#string

Weiguo Jian

http://www.w3.org/2001/XMLSchema#string

P2860

Identification, molecular characterization, clinical prognosis, and therapeutic targeting of human bladder tumor-initiating cells

STATs in cancer inflammation and immunity: a leading role for STAT3

Stat3 as an oncogene

Generation of a concise gene panel for outcome prediction in urinary bladder cancer.

Cancer stem cells in bladder cancer: a revisited and evolving concept

Brief report: molecular biology and the early detection of carcinoma of the bladder--the case of Hubert H. Humphrey.

Three differentiation states risk-stratify bladder cancer into distinct subtypes

Focus on bladder cancer.

Urothelial tumorigenesis: a tale of divergent pathways.

Molecular pathways in invasive bladder cancer: new insights into mechanisms, progression, and target identification.

P304

3135-3142

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/0008-5472.CAN-11-3195

http://www.w3.org/2001/XMLSchema#string

P407

P433

13

http://www.w3.org/2001/XMLSchema#string

P478

72

http://www.w3.org/2001/XMLSchema#string

P577

2012-04-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

224835845

http://www.w3.org/2001/XMLSchema#string

P698

22532166

http://www.w3.org/2001/XMLSchema#string

P932

3418917

http://www.w3.org/2001/XMLSchema#string